Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID‐19: a rapid review and meta‐analysis

B Amani, B Amani - Journal of Medical Virology, 2023 - Wiley Online Library
This study aimed to examine the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for
coronavirus disease 2019 (COVID‐19). PubMed, Cochrane Library, Web of Science …

[HTML][HTML] Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics

Y Gupta, OV Savytskyi, M Coban, A Venugopal… - Molecular Aspects of …, 2023 - Elsevier
With more than 5 million fatalities and close to 300 million reported cases, COVID-19 is the
first documented pandemic due to a coronavirus that continues to be a major health …

HIV and COVID-19: review of clinical course and outcomes

LK Barbera, KF Kamis, SE Rowan… - HIV research & …, 2021 - Taylor & Francis
Background: Understanding the relationship between HIV and SARS-CoV-2 has important
public health implications. Objective: To summarize current research on COVID-19 among …

Efficacy and safety of ivermectin for the treatment of COVID-19: a systematic review and meta-analysis

J Deng, F Zhou, S Ali, K Heybati, W Hou… - … Journal of Medicine, 2021 - academic.oup.com
Background Ivermectin became a popular choice for COVID-19 treatment among clinicians
and the public following encouraging results from pre-print trials and in vitro studies. Early …

Artesunate, imatinib, and infliximab in COVID‐19: A rapid review and meta‐analysis of current evidence

B Amani, S Zareei, B Amani, M Zareei… - Immunity …, 2022 - Wiley Online Library
Abstract Background and Objective Despite the pervasive vaccination program against
coronavirus disease 2019 (COVID‐19), fully vaccinated people are still being infected by …

Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case–control study

A De Vito, M Poliseno, A Colpani, B Zauli… - Current Medical …, 2022 - Taylor & Francis
Introduction Since the start of the SARS-CoV-2 pandemic, several treatment options have
been proposed (eg steroids, heparin, antivirals and monoclonal antibodies). Remdesivir …

Prior statin vs in-hospital statin usage in severe COVID-19: review and meta-analysis

I Alhallak, H Paydak, JL Mehta - Current Problems in Cardiology, 2023 - Elsevier
Studies have shown that statins can decrease COVID-19 mortality in hospitalized patients.
This paper evaluates these studies and reviews the possible mechanism of how statins …

HIV and COVID-19 disease

JP Venturas - Seminars in Respiratory and Critical Care …, 2023 - thieme-connect.com
Despite effective antiretroviral therapy (ART), HIV infected individuals throughout the world
remain at significant risk of respiratory infections and non-communicable disease. Severe …

Spectral-domain OCT measurements in obesity: A systematic review and meta-analysis

MA Salehi, A Karimi, S Mohammadi, JF Arevalo - PloS one, 2022 - journals.plos.org
Background Previous studies proposed possible applications of spectral-domain optical
coherence tomography (SD-OCT) measurements in prognosticating pathologies observed …

Antiviral therapy of COVID-19

G Gudima, I Kofiadi, I Shilovskiy, D Kudlay… - International Journal of …, 2023 - mdpi.com
Since the beginning of the COVID-19 pandemic, the scientific community has focused on
prophylactic vaccine development. In parallel, the experience of the pharmacotherapy of this …